Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
YDKG
3026
Yueda Digital Holding
YDKG
$4.76M
| $235K | ﹤0.01% |
35
-75
| -68% | -$458K |
2015 Q4
3 quarters
|
|
3027
Magnachip Semiconductor
MX
$114M
| $234K | ﹤0.01% |
+28,031
| New | +$204K |
2016 Q3
0 quarters
|
|
|
CBAY
3028
DELISTED
Cymabay Therapeutics
CBAY
| $234K | ﹤0.01% |
120,800
-7,500
| -6% | -$14.9K |
2015 Q4
3 quarters
|
|
|
TAHO
3029
DELISTED
Tahoe Resources Inc
TAHO
| $233K | ﹤0.01% |
18,200
-808,352
| -98% | -$12M |
2016 Q1
2 quarters
|
|
|
ARAV
3030
DELISTED
Aravive, Inc. Common Stock
ARAV
| $232K | ﹤0.01% |
+3,150
| New | +$228K |
2016 Q3
0 quarters
|
|
|
TCPI
3031
DELISTED
TCP International Hldgs Ltd.
TCPI
| $232K | ﹤0.01% |
180,000
-1,200
| -0.7% | -$1.7K |
2015 Q1
6 quarters
|
|
|
CCLP
3032
DELISTED
CSI Compressco LP
CCLP
| $231K | ﹤0.01% |
+21,800
| New | +$201K |
2016 Q3
0 quarters
|
|
|
CBMX
3033
DELISTED
CombiMatrix Corporation
CBMX
| $231K | ﹤0.01% |
82,191
+27,400
| +50% | +$87.2K |
2015 Q1
6 quarters
|
|
3034
Gyre Therapeutics
GYRE
$746M
| $227K | ﹤0.01% |
1,666
+754
| +83% | +$114K |
2014 Q2
9 quarters
|
|
|
ERS
3035
DELISTED
Empire Resources, Inc.
ERS
| $227K | ﹤0.01% |
46,300
+11,500
| +33% | +$52K |
2014 Q2
9 quarters
|
|
|
SIFY
3036
Sify Technologies
SIFY
$931M
| $226K | ﹤0.01% |
36,867
+11,583
| +46% | +$76.8K |
2014 Q4
7 quarters
|
|
|
CMLS
3037
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $226K | ﹤0.01% |
85,595
+59,550
| +229% | +$170K |
2016 Q2
1 quarter
|
|
3038
Aehr Test Systems
AEHR
$2.76B
| $224K | ﹤0.01% |
69,900
-4,700
| -6% | -$9.66K |
2013 Q2
13 quarters
|
|
|
FABC
3039
Fabric.AI Inc
FABC
$15.8M
| $224K | ﹤0.01% |
11
+2
| +22% | +$42.8K |
2015 Q3
4 quarters
|
|
3040
Optical Cable Corp
OCC
$140M
| $224K | ﹤0.01% |
89,400
| – | – |
2013 Q2
13 quarters
|
|
|
STV
3041
DELISTED
China Digital Tv Hldgs Co Ltd
STV
| $224K | ﹤0.01% |
193,076
+105,178
| +120% | +$130K |
2013 Q2
13 quarters
|
|
|
PER
3042
DELISTED
SANDRIDGE PERMIAN TRUST
PER
| $223K | ﹤0.01% |
78,110
-11,445
| -13% | -$30K |
2015 Q4
3 quarters
|
|
|
CPAC
3043
Cementos Pacasmayo
CPAC
$1.05B
| $222K | ﹤0.01% |
18,880
+9,120
| +93% | +$106K |
2015 Q2
5 quarters
|
|
|
ELSE
3044
DELISTED
Electro-Sensors
ELSE
| $222K | ﹤0.01% |
63,200
+1,100
| +2% | +$3.84K |
2013 Q2
13 quarters
|
|
3045
Lightpath Technologies
LPTH
$681M
| $222K | ﹤0.01% |
123,800
-37,300
| -23% | -$68.3K |
2015 Q4
3 quarters
|
|
3046
Unity Bancorp
UNTY
$546M
| $222K | ﹤0.01% |
+17,301
| New | +$202K |
2016 Q3
0 quarters
|
|
|
EDN
3047
Edenor
EDN
$885M
| $220K | ﹤0.01% |
11,098
-25,502
| -70% | -$444K |
2013 Q2
13 quarters
|
|
|
ATYR
3048
aTyr Pharma
ATYR
$24.1M
| $220K | ﹤0.01% |
+4,943
| New | +$214K |
2016 Q3
0 quarters
|
|
3049
eGain
EGAN
$139M
| $219K | ﹤0.01% |
71,000
+14,500
| +26% | +$41K |
2015 Q3
4 quarters
|
|
3050
Peraso
PRSO
$6.06M
| $218K | ﹤0.01% |
36
+9
| +33% | +$46.3K |
2016 Q1
2 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.